R

Recor Medical Tech Stack

FDA-approved ultrasound renal denervation system for hypertension treatment

Medical Equipment Manufacturing Palo Alto, California 201–500 employees Privately Held

Recor Medical is executing a commercial launch of the Paradise ultrasound renal denervation system—an FDA-approved device for hypertension management now being rolled out across U.S. and international markets. The org is heavily sales-driven (28 sales roles against 3 engineering), with active hiring across clinical and market-development functions, signaling a device company in the post-approval, market-penetration phase rather than R&D-focused development. Stack is operations-heavy (QAD, NetSuite, Cornerstone, Jama Connect), typical of regulated manufacturing with strong process controls.

Tech Stack 14 technologies

Core StackSolidWorks Salesforce NetSuite JMP Minitab Microsoft 365 PowerPoint Excel Teams Cornerstone QAD Salesforce Service Cloud Planful Jama Connect

What Recor Medical Is Building

◆Challenges

Launching new medical device
Developing reference sites
Improving patient access
Penetrating high volume prescribers
Increasing device penetration
Launching a new technology
Market adoption
Improving site performance
Adoption of new technology
Identifying new business opportunities

▲Active Projects

Develop launch account strategy
Therapy and market development programs
Reference site development
Launch paradise (ultrasound denervation system)
New program launch
Tailored reimbursement plans for urdn
Patient pipeline development
Cath lab support
Implementing emr flagging criteria
Training content delivery strategy

Hiring Activity

Steady50 roles · 20 in 30d

Department

Sales

28

Healthcare

7

Engineering

3

Research

3

Clinical

1

Data

1

Finance

1

HR

1

Seniority

Manager

24

Senior

12

Mid

7

Director

6

Staff

1

Notable leadership hires: Sales Director

Company intelligence

Find more companies like Recor Medical by tech stack, pain points and active projects

Get started free

About Recor Medical

Recor Medical is a medical device company owned by Otsuka Medical Devices, headquartered in Palo Alto. The company develops and commercializes the Paradise Ultrasound Renal Denervation system for treating hypertension. The device holds FDA approval in the U.S., CE mark in Europe, and is under investigation in Japan. The current organizational focus is on market access, reimbursement strategy, reference site development, and clinical adoption across cardiac catheterization labs. Hiring is concentrated in sales and clinical support roles, with active recruitment in the United States, Germany, and Canada.

HeadquartersPalo Alto, California

Company Size201–500 employees

Hiring MarketsUnited States, Germany, Canada

Frequently Asked Questions

What is Recor Medical's main product?

The Paradise Ultrasound Renal Denervation system, an FDA-approved device for hypertension treatment. It is CE-marked in Europe and investigational in Japan.